Scientists conduct 1st human Covid-19 vaccine trials on 45 volunteers

Scientists conduct 1st human Covid-19 vaccine trials on 45 volunteers

- A possible coronavirus vaccine has been developed by the US National Institute of Health (in collaboration with other partners)

- The test was conducted on Monday on 45 males and non-pregnant females between the ages of 18 and 55.

- The patients will receive another vaccination after 28 days

- Experts have warned that a vaccine could take up to 18 months to develop

PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly.co.za News on your News Feed!

Scientists who have been burning the midnight oil studying and researching the coronavirus have now come up with a possible vaccine that has been put on trial.

The US National Institutes of Health, an agency within the US Department of Health and Human Services, conducted the first vaccine on 45 patients to establish whether or not it would be effective in countering the disease, which has been declared a global pandemic.

The tests are also a way to ensure the vaccine does not have any unforeseen side-effects.

Ray of hope as medics conduct first coronavirus vaccine test on 45 patients

Vaccine for coronavirus that has been put to test. Photo:The Mirror.
Source: UGC

READ ALSO: Louis Vuitton to produce hand sanitiser in fight against coronavirus

According to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, the test was an important milestone in the quest to combat the spread of the virus, which has grounded normal operations in many countries across the world.

Ray of hope as medics conduct first coronavirus vaccine test on 45 patients

Scientists in a lab researching and analysing COVID-19 virus. Photo:BBC
Source: UGC

READ ALSO: Idris Elba confirms he’s positive for Covid-19 and in self-isolation

The patients will be subjected to the same vaccine after 28 days to access their response and the performance of the vaccination.

Scientists said the treatment may not be readily available even after the test, noting the vaccination would not be fit for mass use for another 12 to 18 months.

"It's been made to a very high standard, using things that we know are safe to use in people, and those taking part in the trial will be very closely monitored.
"This is very fast but it is a race against the virus, not against each other as scientists, and it's being done for the benefit of humanity," infectious disease expert John Tregoning told BBC.

As it stands, there have been 182 815 cases of coronavirus and a total of 7 174 deaths reported globally.

China has been the worst-hit, followed by Italy and Iran.

So far, at least 79 000 people who contracted the virus have recovered and been discharged from hospitals.

Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!

Source: Briefly.co.za

Mailfire view pixel